- Home
- CPIX vs NTWK Comparison
CPIX vs NTWK Comparison
Compare CPIX & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- NTWK
- Stock Information
- Founded
- CPIX 1999
- NTWK 1997
- Country
- CPIX United States
- NTWK United States
- Employees
- CPIX N/A
- NTWK N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- NTWK Computer Software: Prepackaged Software
- Sector
- CPIX Health Care
- NTWK Technology
- Exchange
- CPIX Nasdaq
- NTWK Nasdaq
- Market Cap
- CPIX 68.7M
- NTWK N/A
- IPO Year
- CPIX 2009
- NTWK 1998
- Fundamental
- Price
- CPIX $5.27
- NTWK $2.36
- Analyst Decision
- CPIX
- NTWK
- Analyst Count
- CPIX 0
- NTWK 0
- Target Price
- CPIX N/A
- NTWK N/A
- AVG Volume (30 Days)
- CPIX 287.3K
- NTWK 31.4K
- Earning Date
- CPIX 03-04-2025
- NTWK 02-13-2025
- Dividend Yield
- CPIX N/A
- NTWK N/A
- EPS Growth
- CPIX N/A
- NTWK N/A
- EPS
- CPIX N/A
- NTWK N/A
- Revenue
- CPIX $37,867,945.00
- NTWK $62,048,128.00
- Revenue This Year
- CPIX N/A
- NTWK N/A
- Revenue Next Year
- CPIX N/A
- NTWK N/A
- P/E Ratio
- CPIX N/A
- NTWK N/A
- Revenue Growth
- CPIX N/A
- NTWK 9.28
- 52 Week Low
- CPIX $1.04
- NTWK $2.28
- 52 Week High
- CPIX $7.25
- NTWK $3.34
- Technical
- Relative Strength Index (RSI)
- CPIX 54.39
- NTWK 44.25
- Support Level
- CPIX $4.64
- NTWK $2.33
- Resistance Level
- CPIX $5.60
- NTWK $2.54
- Average True Range (ATR)
- CPIX 0.76
- NTWK 0.10
- MACD
- CPIX -0.12
- NTWK -0.00
- Stochastic Oscillator
- CPIX 32.82
- NTWK 50.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.